Last Updated: 14-08-2025 | Format: PDF | Report ID:20869 | Author: Abhishek
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $9,195 Million |
| What is the projected market size by 2035? | $15,380 Million |
| What is the market CAGR from 2025 to 2035? | 5.3% |
| Which region dominates the market? | Western Europe (51%) |
| Which product/service type dominates the market? | Breast Cancer (28%) |
| Which application leads the market? | Diagnosis (33%) |
| Who are the major buyers? | Hospitals (47%), Diagnostic Centers (21%) |
| What are the key market growth drivers? | Rising adoption of precision oncology solutions; Expansion of population-based screening programs |
| What are the major market challenges? | Fragmented reimbursement landscape across Europe; Shortage of skilled oncology specialists |
| What is the forecast period? | 2026–2035 |
| Who are the key market players? |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| Roche, AstraZeneca, Novartis, Pfizer, Merck, Johnson & Johnson, Siemens Healthineers, Abbott Laboratories, GE Healthcare, Thermo Fisher Scientific, Bristol Myers Squibb, Illumina, GlaxoSmithKline (GSK), Sanofi, Bayer AG |
US Early Stage Cancer Market Market: by Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Other Cancers), Application (Diagnosis, Screening, Monitoring, Prognosis, Treatment Planning, Other Applications), Distribution Channels (Hospitals, Diagnostic Centers, Research Institutes, Retail Pharmacies, Online Providers, Others), Technology (Imaging, Molecular Diagnostics, Genomics, Biomarker Testing, Others), Organization Size (Small, Medium, Large) and By US Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Europe Early Stage Cancer Market: by Type (Biomarker-based Screening, Imaging-based Screening, Liquid Biopsy, Molecular Diagnostics, Immunoassay, Others), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Others), Distribution Channels (Hospitals, Diagnostic Centers, Cancer Research Institutes, Specialty Clinics, Ambulatory Surgical Centers, Others), Technology (PCR, Next-Generation Sequencing, Immunohistochemistry, In Situ Hybridization, Flow Cytometry, Others), Organization Size (Small, Medium, Large) and By Europe Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Transfection Reagents and Equipment Market: by Type (Reagents, Instruments), Application (Biomedical Research, Therapeutic Delivery, Protein Production, Cancer Research, Gene Therapy, Others), Distribution Channels (Direct Tenders, Retail Sales, E-commerce, Distributors, Wholesalers, Others), Technology (Physical, Chemical, Biological, Viral-mediated, Electroporation, Lipofection), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America mRNA Synthesis & Manufacturing Market: by Type (Synthetic mRNA, Modified mRNA, Unmodified mRNA, Self-amplifying mRNA, Circular mRNA, Purified mRNA), Application (Vaccines, Cancer Immunotherapy, Protein Replacement Therapy, Gene Editing, Research Applications, Rare Diseases), Distribution Channels (Direct Sales, Distributors, Online Platforms, Retail Pharmacies, Hospital Pharmacies, Others), Technology (In vitro Transcription, Enzymatic Synthesis, Lipid Nanoparticle Formulation, Purification Technologies, Polymerase Chain Reaction, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Long Read Sequencing Market: by Type (Single-Molecule Real-Time (SMRT) Sequencing, Nanopore Sequencing, Synthetic Long-Read Sequencing, Others), Application (De Novo Sequencing, Variant Detection, Transcriptome Analysis, Epigenetics, Cancer Genomics, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Research Institutes, Hospitals, Others), Technology (SMRT Sequencing, Nanopore Sequencing, Linked-Read Sequencing, Synthetic Long-Read Sequencing, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025